Skip to main content

Table 2 Performance of tissue-derived markers in plasma samples (training and validation cohort)

From: Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

Training cohort

Predicted

 

Total

Healthy

Cirrhosis

HCC

Sensitivity (%)

Specificity (%)

Healthy

290

284

3

3

 

98

Cirrhosis

92

14

72

6

 

93

Healthy+Cirrhosis

382

298

75

9

 

98

0-A

72

10

5

57

79

 

B

18

0

1

17

94

 

C-D

30

0

1

29

97

 

HCC

120

10

7

103

86

 

Validation cohort

Predicted

 

Total

Healthy

Cirrhosis

HCC

Sensitivity (%)

Specificity (%)

Healthy

242

241

0

1

 

100

Cirrhosis

111

36

62

13

 

88

Healthy+Cirrhosis

353

277

62

14

 

96

0-A

37

9

0

28

76

 

B

8

1

0

7

88

 

C-D

22

1

0

21

95

 

HCC

67

11

0

56

84

Â